The U.S. Department of Health and Human Services (HHS) announced layoffs within several agencies on April 1, 2025. The dismissals are a part of a sweeping restructuring of the agency, first noticed on March 27, 2025, and spearheaded by HHS Secretary Robert F. Kennedy, Jr. In addition to the lay-offs, senior officials across the agency were offered transitions to other departments. Among those was Dr. Brian King, director of the Center for Tobacco Products (CTP). Dr. King was placed on administrative leave and offered a transfer to the Indian Health Service. Whether he accepted that transfer remains to be seen.
In addition, Secretary Kennedy announced a significant restructuring in late March, which included a combination of personnel cuts, centralization of functions and a consolidation of HHS divisions. Specifically, the U.S. Food and Drug Administration (FDA) will see a decrease of 3,500 full-time employees. However, the announcement specifically noted that the "reduction will not affect drug, medical device, or food reviewers, nor will it impact inspectors."
CDA is carefully monitoring the changes at the FDA and CTP. As new officials are placed into position, CDA will plan to meet with each person and will continue to offer the association and its members as a resource. We will make every effort to share additional information as it becomes available.
Read more on Dr. Brian King being placed on administrative leave
here.
Read more on the FDA staff reductions
here.